Homebiotech

biotech

biotech

Positive topline results from phase 2 recurrent ovarian cancer trial

Jim Cornall - May 26, 2026

biotech

Rare oral cancer has distinct genetic profile

Jim Cornall - May 26, 2026

biotech

New tool decodes structures and motifs of RNA

Jim Cornall - May 26, 2026

biotech

Elite immune cells lead fight against multiple myeloma

Jim Cornall - May 25, 2026

biotech

Pfizer injectable shows continued weight loss in phase 2b trial

Jim Cornall - February 10, 2026

biotech

Skin damage protein ID could lead to new therapies

Jim Cornall - February 10, 2026

biotech

Origami Therapeutics and Ipsen to advance protein degrader programme

Jim Cornall - February 10, 2026

biotech

IQVIA and Boehringer Ingelheim announce data collaboration

Jim Cornall - February 9, 2026

biotech

Next-generation biopreservation for cell therapy

Jim Cornall - February 9, 2026

biotech

Predicting cancer evolution

Jim Cornall - February 9, 2026

biotech

Base to Base biotech podcast 45: Chronic pain, urology, Affibody molecules and radioligand therapy

Jim Cornall - February 6, 2026

biotech

Johnson & Johnson prostate cancer drug receives CHMP positive opinion

Jim Cornall - February 5, 2026

1...232425...78 Page 24 of 78

Stay Connected

- Advertisement -

spot_img

Latest Articles

biotech

Positive topline results from phase 2 recurrent ovarian cancer trial

Jim Cornall - May 26, 2026 0

OSE Immunotherapeutics SA has announced the release of the abstract selected for an oral presentation at the upcoming ASCO 2026 annual meeting, unveiling topline...

Rare oral cancer has distinct genetic profile

biotech Jim Cornall - May 26, 2026 0

New tool decodes structures and motifs of RNA

biotech Jim Cornall - May 26, 2026 0

Elite immune cells lead fight against multiple myeloma

biotech Jim Cornall - May 25, 2026 0

National framework to strengthen UK advanced therapy clinical trials

biotech Jim Cornall - May 25, 2026 0